Literature DB >> 29054440

External validation of heart-type fatty acid binding protein, high-sensitivity cardiac troponin, and electrocardiography as rule-out for acute myocardial infarction.

Christopher B Van Hise1, Jaimi H Greenslade2, William Parsonage3, Martin Than4, Joanna Young5, Louise Cullen6.   

Abstract

OBJECTIVE: To externally validate a clinical decision rule incorporating heart fatty acid binding protein (h-FABP), high-sensitivity troponin (hs-cTn) and electrocardiogram (ECG) for the detection of acute myocardial infarction (AMI) on presentation to the Emergency Department. We also investigated whether this clinical decision rule improved identification of AMI over algorithms incorporating hs-cTn and ECG only. DESIGN AND METHODS: This study included data from 789 patients from the Brisbane ADAPT cohort and 441 patients from the Christchurch TIMI RCT cohort. The primary outcome was index AMI. Sensitivity, specificity, positive predictive value and negative predictive value were used to assess the diagnostic accuracy of the algorithms.
RESULTS: 1230 patients were recruited, including 112 (9.1%) with AMI. The algorithm including h-FABP and hs-cTnT had 100% sensitivity and 32.4% specificity. The algorithm utilising h-FABP and hs-cTnI had similar sensitivity (99.1%) and higher specificity (43.4%). The hs-cTnI and hs-cTnT algorithms without h-FABP both had a sensitivity of 98.2%; a result that was not significantly different from either algorithm incorporating h-FABP. Specificity was higher for the hs-cTnI algorithm (68.1%) compared to the hs-cTnT algorithm (33.0%). The specificity of the algorithm incorporating hs-cTnI alone was also significantly higher than both of the algorithms incorporating h-FABP (p<0.01).
CONCLUSION: For patients presenting to the Emergency Department with chest pain, an algorithm incorporating h-FABP, hs-cTn and ECG has high accuracy and can rule out up to 40% of patients. An algorithm incorporating only hs-cTn and ECG has similar sensitivity and may rule out a higher proportion of patients. Each of the algorithms can be used to safely identify patients as low risk for AMI on presentation to the Emergency Department.
Copyright © 2017 The Canadian Society of Clinical Chemists. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29054440     DOI: 10.1016/j.clinbiochem.2017.10.001

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  4 in total

1.  Heart-type fatty acid-binding protein: an overlooked cardiac biomarker.

Authors:  Harsh Goel; Joshua Melot; Matthew D Krinock; Ashish Kumar; Sunil K Nadar; Gregory Y H Lip
Journal:  Ann Med       Date:  2020-08-04       Impact factor: 4.709

Review 2.  The Biomarkers for Acute Myocardial Infarction and Heart Failure.

Authors:  Xi-Ying Wang; Fen Zhang; Chi Zhang; Liang-Rong Zheng; Jian Yang
Journal:  Biomed Res Int       Date:  2020-01-17       Impact factor: 3.411

3.  Development of a Point-of-Care Test Based on Selenium Nanoparticles for Heart-Type Fatty Acid-Binding Proteins in Human Plasma and Blood.

Authors:  Lanju Wang; Mengli Wu; Jingjing Ma; Ziwei Ma; Jiahui Liang; Ningya Tao; Yangguang Ren; Shujun Shao; Xin Qi; Zhizeng Wang
Journal:  Int J Nanomedicine       Date:  2022-03-22

4.  e-Transmission of ECGs for expert consultation results in improved triage and treatment of patients with acute ischaemic chest pain by ambulance paramedics.

Authors:  S S Anroedh; I Kardys; K M Akkerhuis; M Biekart; B van der Hulst; G J Deddens; P Smits; M Gardien; E Dubois; F Zijlstra; E Boersma
Journal:  Neth Heart J       Date:  2018-11       Impact factor: 2.380

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.